SCHEMBL30690802

SCHEMBL30690802

Cc1ccc(C(=O)NCCN2CCCCC2)cc1NC(=O)c1cnc2c(c1)cc(-c1cnn(C)c1)n2COCC[Si](C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.40
PDGFRA P16234 2/20 0.40
CHRM1 P11229 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
MAPK14 Q16539 3/20 0.40
KIT P10721 1/20 0.40
PIR O00625 2/20 0.39
LCK P06239 2/20 0.39
KDR P35968 2/20 0.39
BRAF P15056 1/20 0.39
GSK3B P49841 1/20 0.39
HSF1 Q00613 1/20 0.39
MCHR1 Q99705 4/20 0.38
PTGER4 P35408 1/20 0.38
KMT2A Q03164 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30690788 0.82 PDGFRA (0.40) ABL1PDGFRACHRM1HRH3KIT
SCHEMBL30690812 0.82 PDGFRA (0.60) ABL1PDGFRACHRM1HRH3KIT
SCHEMBL30690685 0.82 PDGFRA (0.42) ABL1PDGFRACHRM1HRH3MAPK14
SCHEMBL30690774 0.81 GSK3B (0.41) PDGFRACHRM1HRH3KITGSK3B
SCHEMBL30690679 0.81 PDGFRA (0.40) ABL1PDGFRACHRM1HRH3KIT
SCHEMBL30690821 0.80 PDGFRA (0.38) ABL1PDGFRAKITKDRGSK3B
SCHEMBL30690683 0.79 PDGFRA (0.39) ABL1PDGFRACHRM1HRH3KIT
SCHEMBL30690781 0.79 PDGFRA (0.39) ABL1PDGFRACHRM1HRH3KIT
Hydrochloric Acid SCHEMBL30690806 0.78 PDGFRA (0.38) ABL1PDGFRACHRM1HRH3KIT
SCHEMBL27277523 0.78 ABL1 (0.49) ABL1PDGFRACHRM1HRH3KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023247593-A1 PYRROLOPYRIDINE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-12-28 WO disclosed